Final Days to Register: 2 Day Interactive Risk-based Computer System Validation Course: Reduce Costs and Avoid 483 – October 4-5, 2022 – QNT Press Release

[ad_1]

DUBLIN, Sept. 26, 2022 /PRNewswire/ — The “Risk-based Computer System Validation; Reduce Costs and Avoid 483” training has been added to ResearchAndMarkets.com’s offering.

This highly interactive two-day course uses real life examples and explores proven techniques for reducing costs, usually by two-thirds, associated with implementing, and maintaining computer systems in regulated environments.

  • It details the requirements for Part 11 and Annex 11: SOPs, software product features, infrastructure qualification, and validation.
  • The instructor addresses the latest computer system industry standards for data security, data transfer, audit trails, electronic records and signatures, software validation, and computer system validation.
  • Understand the specific requirements associated with local and SaaS/cloud hosting solutions.
  • Nearly every computerized system used in laboratory, clinical, manufacturing settings and in the quality process has to be validated. learn Participants how to decrease software implementation times and lower costs using a 10-step risk-based approach to computer system validation.
  • The instructor reviews recent FDA inspection trends and discusses how to streamline document authoring, revision, review, and approval.
  • Participants will learn how to write a Data Privacy Statement to comply with the EU General Data Protection Regulation (GDPR).
  • This course benefits anyone that uses computer systems to perform their job functions and is ideal for professionals working in the health care, clinical trial, biopharmaceutical, and medical device sectors. It is essential for software vendors, auditors, and quality staff involved in GxP applications .

Learning Objectives:

  • Reduce costs, usually by two-thirds, for compliance with electronic records
  • Learn how to use electronic records and electronic signatures to…

Full story available on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center